mevastatin has been researched along with panobinostat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Jiang, L; Jiang, X; Kou, X; Lin, Z; Ling, S; Liu, H; Qin, N; Sun, F; Yang, Y; Zhang, Z | 1 |
1 other study(ies) available for mevastatin and panobinostat
| Article | Year |
|---|---|
Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Beclin-1; Cell Line, Tumor; Class III Phosphatidylinositol 3-Kinases; Female; G2 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lovastatin; Lysosomes; Mice; Mice, Inbred BALB C; Mice, Nude; Panobinostat; Protein Serine-Threonine Kinases; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2017 |